Safety Evaluation & Risk Management; SERM Scientific Director

At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting‑edge technology to transform people’s lives. We foster a culture ambitious for patients, accountable for impact, and committed to doing the right thing.

We’re uniting science, technology, and talent to get ahead of disease together.

The SERM Scientific Director will provide in-depth medical/scientific expertise in the safety evaluation and risk management of key GSK assets or in clinical development and/or the post‑marketing setting.

Ensures scientifically sound review and interpretation of data and management of safety issues and escalates safety issues identified through the safety review process to senior management and safety governance as appropriate. Makes recommendations for the further characterization, management, and communication of safety risks.

Focus on efficiency and effectiveness to meet the needs of our Patients and HCPs. Supporting the pharmacovigilance and benefit‑risk management of the assigned portfolio of GSK global assets to ensure Patient Safety globally.

• Leads Pharmacovigilance and Risk Management Planning and develops strategy for approach to evaluation of issues in the clinical matrix.
• Leads the safety component of global regulatory submissions.
• Expert evaluation skills and analytical thinking for literature review, clinical data synthesis, analysis and interpretation.
• Demonstrated track record of quality decision making and creative problem resolution, based on assessment of all relevant supporting and conflicting information/factors and understanding of the wider context.
• Demonstrates highly developed multi‑tasking skills, ability to prioritise tasks and consistently delivers on deadlines, with high performance standards for quality.
• Explores positions and alternatives to reach mutually beneficial agreements and solutions.

• Leads safety governance by development of safety strategy and its execution for products in clinical development and post‑marketing settings. Anticipates, detects and addresses product safety issues (e.g., product incidents) and ensures that risk‑reduction strategies are implemented appropriately.
• Facilitates safety governance/SRTs in the clinical development and post‑marketing settings by assisting in the establishment and operation of cross‑functional teams in any SERM to detect and address product safety issues and ensures that risk‑reduction strategies are implemented appropriately in clinical study protocols and/or product labelling.
• Represents GS on cross‑functional Clinical Matrix Teams and/or Project Teams. Leads cross‑functional ad hoc teams to address urgent and important product safety issues.
• Leads or participates in cross‑functional process initiatives and/or Process Work streams to drive efforts to improve adherence to regulations, data standards, quality and efficiency.
• Authors/participates in written standard updates (e.g., SOPs) to ensure policies and regulations are being adhered to correctly and consistently.
• Accountable for the escalation of issues and communication on safety matters (e.g., GSB, CHSLC, GLC, QPPV).
• Builds strong working relationships and displays excellent leadership skills on safety issues whilst working in a matrix team, with a demonstrated ability to lead a team in a matrix setting. Ability to coach and mentor others.

• Leads presentations on recommendations or safety issues to senior staff members at the GSK Senior Governance Committees. Has the skillset to interact with confidence, credibility, and influence at all levels of the GSK organisation. In addition, is expected to represent GSK and contribute to safety related discussions at meetings with regulatory authorities, outside consultants and other companies such as licensing partners.
• Leads cross‑functional process improvement team within GSK. Thinks…